[PRLD] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
10-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 12.79%
YoY- -34.47%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -28,641 -29,958 -27,374 -29,465 -32,842 -30,687 -26,865 4.34%
Tax -7,654 -448 -2,087 -823 -168 -356 -290 781.19%
NP -20,987 -29,510 -25,287 -28,642 -32,842 -30,687 -26,865 -15.13%
Tax Rate - - - - - - - -
Total Cost 20,987 29,510 25,287 28,642 32,842 30,687 26,865 -15.13%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.44 -0.62 -0.53 -0.61 -0.71 -0.66 -0.58 -16.77%
EPS Diluted -0.44 -0.62 -0.53 -0.61 -0.71 -0.66 -0.58 -16.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.